Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura M. Reffert"'
Autor:
Kathrin Kettenbach, Laura M. Reffert, Hanno Schieferstein, Stefanie Pektor, Raphael Eckert, Matthias Miederer, Frank Rösch, Tobias L. Ross
Publikováno v:
Pharmaceuticals, Vol 11, Iss 1, p 30 (2018)
Within the last decade, several folate-based radiopharmaceuticals for Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have been evaluated; however, there is still a lack of suitable 18F-folates for clinical P
Externí odkaz:
https://doaj.org/article/fa05f5cd5d5f4b24b3022c575522d58a
Autor:
Frank M. Bengel, Zekiye Korkmaz, James T. Thackeray, Laura B.N. Langer, Jens P. Bankstahl, Laura M. Reffert, Annika Hess, Jochen Tillmanns, Tobias L. Ross
Publikováno v:
Theranostics
Background: Myocardial infarction (MI) evokes an organized remodeling process characterized by the activation and transdifferentiation of quiescent cardiac fibroblasts to generate a stable collagen rich scar. Early fibroblast activation may be amenab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3732c7d2f2fe6b8fa1cf1a2f0cdbe0be
http://europepmc.org/articles/PMC8315078
http://europepmc.org/articles/PMC8315078
Autor:
Frank Rösch, Tobias L. Ross, Raphael Eckert, Laura M. Reffert, Matthias Miederer, Hanno Schieferstein, Stefanie Pektor, Kathrin Kettenbach
Publikováno v:
Pharmaceuticals
Pharmaceuticals; Volume 11; Issue 1; Pages: 30
Pharmaceuticals, Vol 11, Iss 1, p 30 (2018)
Pharmaceuticals; Volume 11; Issue 1; Pages: 30
Pharmaceuticals, Vol 11, Iss 1, p 30 (2018)
Within the last decade, several folate-based radiopharmaceuticals for Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have been evaluated; however, there is still a lack of suitable 18F-folates for clinical P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3972600f4a1db87b4cc8f7b3a5823403
http://europepmc.org/articles/PMC5874726
http://europepmc.org/articles/PMC5874726
Autor:
Laura M. Reffert, Tobias L. Ross, Kathrin Kettenbach, Hanno Schieferstein, Nicolas H. Bings, Catrin Grunewald, C. Schütz, G. Hampel, Dorothee Iffland
Publikováno v:
Radiochimica Acta. 103:799-809
Boron neutron capture therapy (BNCT) employs 10B-pharmaceuticals administered for the treatment of malignancies, and subsequently irradiated with thermal neutrons. So far, clinical established pharmaceuticals like boron phenylalanine (BPA) or sodium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b96094c3503fa7d88cd65835a2bb3c28
https://doi.org/10.1515/ract-2014-2360
https://doi.org/10.1515/ract-2014-2360